Cumberland Pharmaceuticals Inc (Cumberland Pharma) is a provider of generic products. The company acquires, develops and commercializes prescription products for hospitals, acute cares, unmet medical needs, and gastroenterology. Its products comprise acetadote, kristalose, hepatoren, omeclamox, vaprisol, and caldolor. Cumberland Pharma’s acetadote is used for the prevention of liver damage resulting from acetaminophen overdose. The company’s caldolor is indicated in adults and pediatric patients six months and older for the management of mild to moderate pain and the management of moderate to severe pain as an adjunct to opioid analgesics. It sells its products through a network of distributors in the US and abroad. Cumberland Pharma is headquartered in Nashville, Tennessee, the US. GlobalData’s Cumberland Pharmaceuticals Inc (CPIX) - Financial and Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years. This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering world’s leading companies.